|
|
5-day change | 1st Jan Change | ||
|
582.56 USD |
+0.89% | -0.70% | +8.99% | |
Published on 05/08/2025 at 09:17
© MT Newswires – 2025
|
RBC Lifts Price Target on Chemed to $674 From $667, Keeps Outperform Rating |
Apr. 28 |
MT |
|
Chemed Corporation, Q1 2025 Earnings Call, Apr 24, 2025 |
Apr. 24 |
|
|
Chemed Q1 Adjusted Earnings, Revenue Rise |
Apr. 23 |
MT |
|
Tranche Update on Chemed Corporation’s Equity Buyback Plan announced on February 22, 2011. |
Apr. 23 |
CI |
|
Chemed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 |
Apr. 23 |
CI |
|
Earnings Flash (CHE) CHEMED CORPORATION Posts Q1 Revenue $646.9M, vs. FactSet Est of $641.8M |
Apr. 23 |
MT |
|
Earnings Flash (CHE) CHEMED CORPORATION Posts Q1 Adjusted EPS $5.63, vs. FactSet Est of $5.55 |
Apr. 23 |
MT |
|
John Chevedden Submits Shareholder Proposal with Chemed Corporation |
Apr. 07 |
CI |
|
Chemed Corporation Solicits Proxies from Shareholders |
Apr. 07 |
CI |
|
Chemed Insider Sold Shares Worth $615,330, According to a Recent SEC Filing |
Apr. 01 |
MT |
|
Chemed Corporation Presents at Oppenheimer 35th Annual Health Care MedTech and Services Conference, Mar-17-2025 09:20 AM |
Mar. 17 |
|
|
RBC Raises Price Target on Chemed to $667 From $633, Keeps Outperform Rating |
Mar. 14 |
MT |
|
Chemed Insider Sold Shares Worth $1,187,340, According to a Recent SEC Filing |
Mar. 07 |
MT |
|
Chemed Insider Sold Shares Worth $785,324, According to a Recent SEC Filing |
Mar. 03 |
MT |
|
Chemed Corporation, Q4 2024 Earnings Call, Feb 27, 2025 |
Feb. 27 |
|
|
Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set |
Feb. 26 |
MT |
|
Tranche Update on Chemed Corporation’s Equity Buyback Plan announced on February 22, 2011. |
Feb. 26 |
CI |
|
Chemed Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 |
Feb. 26 |
CI |
|
Earnings Flash (CHE) CHEMED CORPORATION Posts Q4 Revenue $640M, vs. FactSet Est of $636.1M |
Feb. 26 |
MT |
|
Earnings Flash (CHE) CHEMED CORPORATION Reports Q4 Adjusted EPS $6.83, vs. FactSet Est of $6.78 |
Feb. 26 |
MT |
|
Chemed Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM |
Jan. 14 |
|
|
Chemed Corporation Presents at Bank of America Home Care Conference, Dec-10-2024 01:20 PM |
Dec. 10 |
|
|
Chemed Insider Sold Shares Worth $421,356, According to a Recent SEC Filing |
Nov. 29 |
MT |
|
Chemed Insider Sold Shares Worth $565,710, According to a Recent SEC Filing |
Nov. 22 |
MT |
|
Chemed Corporation Presents at UBS Global Healthcare Conference 2024, Nov-12-2024 11:45 AM |
Nov. 12 |
CHE: Dynamic Chart
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.
More about the company
Buy
Last Close Price
577.44USD
Average target price
677.33USD
Spread / Average Target
+17.30%
Consensus
Select your edition
All financial news and data tailored to specific country editions
